TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
DMRA

Damora Therapeutics, Inc.

Healthcare · Biotechnology

20.70$ -0.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DMRA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – 0.00 0.00 0.00 0.00 0.00
– 0.11 0.19 0.44 0.48 0.78 0.16 0.02
– -0.11 -0.19 -0.44 -0.48 -0.78 -0.16 -0.02
9.92 35.90 24.37 38.09 47.43 22.36 5.53 147.61
– – – 13.60 12.79 11.94 9.07 7.11
12.69 38.19 33.10 51.25 59.74 33.52 14.45 154.71
-12.69 -38.30 -33.29 -51.69 -60.22 -34.30 -14.60 -154.71
2.92 – – – – – – –
-15.60 -35.88 -34.48 -51.22 -60.63 -36.08 -18.49 -153.92
– – – – – – 0.04 0.04
-15.60 -35.88 -34.48 -51.22 -60.63 -36.08 -18.53 -153.95
-12.69 -38.19 -33.10 -50.78 -60.15 -35.30 -18.34 -153.89

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?